stoxline Quote Chart Rank Option Currency Glossary
  
DaVita Inc. (DVA)
142.69  2.83 (2.02%)    06-12 16:00
Open: 140.38
High: 143.62
Volume: 683,973
  
Pre. Close: 139.86
Low: 139.81
Market Cap: 12,514(M)
Technical analysis
2024-06-12 4:21:38 PM
Short term     
Mid term     
Targets 6-month :  172.78 1-year :  201.8
Resists First :  147.92 Second :  172.78
Pivot price 142.35
Supports First :  137.73 Second :  131.44
MAs MA(5) :  142.22 MA(20) :  141.45
MA(100) :  130.51 MA(250) :  111.06
MACD MACD :  1.6 Signal :  2
%K %D K(14,3) :  60.2 D(3) :  63.6
RSI RSI(14): 54
52-week High :  147.92 Low :  71.51
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ DVA ] has closed below upper band by 48.0%. Bollinger Bands are 27.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 143.95 - 144.91 144.91 - 145.77
Low: 137.45 - 138.67 138.67 - 139.77
Close: 140.81 - 142.73 142.73 - 144.46
Company Description

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Headline News

Wed, 12 Jun 2024
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch

Wed, 12 Jun 2024
Cubist Systematic Strategies LLC Has $14.28 Million Stock Position in DaVita Inc. (NYSE:DVA) - MarketBeat

Wed, 12 Jun 2024
Bridgewater Associates LP Cuts Stock Holdings in DaVita Inc. (NYSE:DVA) - Defense World

Wed, 12 Jun 2024
Connectus Wealth LLC Buys New Holdings in DaVita Inc. (NYSE:DVA) - Defense World

Wed, 12 Jun 2024
DaVita Inc. (NYSE:DVA) Shares Bought by Ossiam - Defense World

Tue, 11 Jun 2024
8 Knots Management LLC Makes New Investment in DaVita Inc. (NYSE:DVA) - MarketBeat

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Care Facilities
Shares Out 88 (M)
Shares Float 48 (M)
Held by Insiders 45.1 (%)
Held by Institutions 50.1 (%)
Shares Short 3,530 (K)
Shares Short P.Month 3,640 (K)
Stock Financials
EPS 8.81
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 10.56
Profit Margin 6.6 %
Operating Margin 14.3 %
Return on Assets (ttm) 6.3 %
Return on Equity (ttm) 43.2 %
Qtrly Rev. Growth 6.9 %
Gross Profit (p.s.) 0
Sales Per Share 140.7
EBITDA (p.s.) 28.39
Qtrly Earnings Growth 112 %
Operating Cash Flow 1,460 (M)
Levered Free Cash Flow 564 (M)
Stock Valuations
PE Ratio 16.17
PEG Ratio 1.1
Price to Book value 13.51
Price to Sales 1.01
Price to Cash Flow 8.57
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android